Philips Agrees Terms Of US Consent Decree, Remains Bullish On 2024
CEO proclaims light at the end of the tunnel of Respironics recalls
Royal Philips CEO Roy Jakobs updated investors on progress of the company’s operating plan 2023-25, US actions and litigation on the Respironics portfolio, patient safety, quality and the order book as it announced Q4 2023 revenues.
